Connect with us

Technology

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

Published

on

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery through clinical readiness, today announced its launch as a specialist partner uniquely positioned to advance and accelerate cell-based treatments to patients.

NueCell Bio is led by a team possessing unprecedented experience in the advanced therapies market. The team’s industry-leading expertise in supporting customers developing novel cell therapies positions NueCell Bio to offer customizable modular technologies to engineer cells and develop scalable, GMP-ready manufacturing processes and analytics for a wide range of cell therapies. NueCell Bio works across a broad spectrum of groundbreaking science in this field, including CAR-T, stem cells, iPSC-derived therapies, gene-edited cells, and tissue repair platforms – supporting both autologous and allogeneic products.

NueCell Bio is headquartered in the Sorrento Valley area of San Diego – a leading hub for biotechnology and advanced therapy development – in a 26,300 square-foot, state-of-the-art facility that specializes in translational services for cell therapy.

“Advanced therapies, including cell therapies, are expanding rapidly across the United States, Europe, Japan, South Korea, and emerging biotechnology markets,” said Michael Wourms, Chief Executive Officer of NueCell Bio. “The industry does not suffer from a shortage of scientific breakthroughs, it suffers from a difficulty in efficiently converting these breakthroughs into therapies that can be evaluated, manufactured, and ultimately delivered to patients. That translational phase is where NueCell Bio is focused. By combining NueCell’s flexible and modular translational development solutions with scientific expertise, analytical capabilities, and a proven track record, we believe we are uniquely positioned to help innovators advance the next generation of cellular therapies for cancer, immune-mediated diseases, tissue repair and regeneration, and other areas of significant unmet medical need.”

“NueCell Bio is distinctively positioned to advance cell therapies from early discovery through clinical development,” said Dr. Uma Lakshmipathy, Co-founder and Chief Science Officer. “Cell therapies have been proven to work and are commercially available, but manufacturing them at scale is still slow and expensive, largely because each therapy is biologically unique. The most promising therapies often face the greatest development complexity. Every program follows a different path, and the scientific, analytical, and development challenges that create risk for one company may be very different for another. Our role is to understand where each program is today, identify what is needed to move it forward, and apply the right expertise and resources at the appropriate time to help accelerate its path towards clinical readiness. By combining modular technology stacks of scientific, analytical, process development, and manufacturing-enabling capabilities, NueCell Bio is uniquely positioned to help innovators navigate critical development challenges and advance promising therapies more efficiently to reach patients faster.”

Renowned University of Pennsylvania Professor, Dr. Bruce Levine, a member of NueCell Bio’s Scientific Advisory Board, said, “The ecosystem of advanced therapies I have been part of for many years is moving rapidly and NueCell Bio helps meet the demand by supporting the development of life-altering and life-saving treatments that were previously only a distant hope in many challenging areas of medicine. To reach more patients, the future of cell therapy lies in expanding beyond oncology towards additional broad indications, while still addressing low-incidence diseases. To support this goal, the incorporation of precision engineering, efficient manufacturing processes and advanced analytics is essential.”

“The ability to genetically engineer cells to have the characteristics to treat specific diseases is key, but another very important aspect is successfully advancing these programs from lab research into a GMP manufacturing process that is capable of consistently delivering cells in sufficient quantities and with required characteristics and viability,” said Dr. Gabor Veres, a member of NueCell Bio’s Scientific Advisory Board. “With the expertise of our team and state-of-the-art capabilities, NueCell Bio is well positioned to support customers by developing reliable, consistent and scalable processes suited to clinical manufacturing and future commercialization.”

Addressing the acquisition and the future, Dr. Richard Snyder, Chair of the Board and Co-founder of NueCell Bio, said, “I am incredibly excited by how this business brings together such an extraordinary caliber of leaders in the field, along with the team and assets transitioning to NueCell Bio. Beyond this, our team’s significant industry networks are an equally strong factor in establishing NueCell as a highly differentiated cell therapy services business positioned to address the needs of current and future customers.”

In connection with the transaction, Kineticos Life Sciences served as exclusive advisor to NueCell Bio, with Goodwin Procter LLP serving as legal counsel.

About NueCell Bio

NueCell Bio is a San Diego-based company that works with academic institutions, biotechnology companies and pharmaceutical companies to advance cell therapies from concept and early research into clinical development. Our team brings deep expertise in biology, cell engineering, bioprocessing, and advanced technology integration, supported by modular technology stacks that can be tailored to each program.

NueCell Bio gives clients access to experienced design, development and CMC expertise. By combining scientific excellence, strong quality systems, scalable operations, and ‘customer-first’ engagement, NueCell Bio helps accelerate the journey from scientific discovery to clinical delivery. For more information, visit www.NueCellBio.com 

Media contact:

Connor Halverson
Tel: +1 212 366 4455
Email: connor@thatsnice.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/nuecell-bio-announces-its-launch-as-a-new-translational-partner-for-cell-therapies-with-unique-expertise-to-accelerate-treatments-from-discovery-into-gmp-manufacturing-302841793.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Furrl’s AI styling engine and commerce app acquired by Reliance Retail

Published

on

By

Acquisition to advance Reliance Retail’s AI-first strategy for personalised shopping and discovery

BENGALURU, India, Aug. 5, 2026 /PRNewswire/ — Furrl, a Bengaluru-based AI-powered styling, cataloguing and fashion discovery platform founded by Esha Tiwary, today confirmed that its technology – including its AI Styling Engine and commerce app – has been acquired by Reliance Retail Ventures Limited (RRVL). The acquisition forms part of Reliance Retail’s broader strategy to embed artificial intelligence across its consumer businesses and deliver more personalised, intuitive shopping experiences.

Furrl’s technology transforms fashion catalogues into fully styled outfit recommendations based on individual consumer preferences, helping shoppers discover products in a more contextual and intuitive way. Following the acquisition, the technology is expected to strengthen Reliance Retail’s AI-driven discovery and personalisation capabilities across its digital and omni-channel platforms.

Founded in 2022, Furrl set out to solve fashion discovery given rapidly changing consumer preferences – starting with a catalogue focused on D2C fashion brands, and subsequently developing an AI Styling Engine to help shoppers go from browsing endless catalogues to seeing complete outfits styled specifically for them. Over the past four years, the company scaled its platform across more than 50,000 products from 200+ fashion and lifestyle brands, building deep technical capability in catalogue intelligence, personalisation and outfit-level recommendation.

Commenting on the development, Esha Tiwary, Founder of Furrl, said, “We built Furrl with one conviction: that fashion discovery is broken and AI can fundamentally change that. This acquisition enables our technology to reach millions of customers with Reliance Retail’s scale, and is a powerful validation of what our team built.”

About Furrl:

Furrl (operated by Kleosa Retail Private Limited) is a Bengaluru-based AI-powered styling, cataloguing and fashion discovery platform founded by Esha Tiwary in 2022. The company built an AI Styling Engine that converted product catalogues into personalised, styled outfit recommendations, alongside a consumer-facing commerce app for D2C fashion brands, scaling to over 50,000 products across 200+ brands. In 2026, Furrl’s technology and IP were acquired by Reliance Retail Ventures Limited.

Logo: https://mma.prnewswire.com/media/3008673/6030983/Furrl_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/furrls-ai-styling-engine-and-commerce-app-acquired-by-reliance-retail-302843478.html

Continue Reading

Technology

MapFour Roam Officially Launches, Bringing Premium Trekking Experience Within Reach

Published

on

By

BERLIN, Aug. 5, 2026 /PRNewswire/ — MapFour officially launches the Roam series, featuring both the Roam (step-over) and Roam ST (step-through). Designed as a full-suspension trekking e-bike with smart protection, the series delivers premium comfort, intelligent security, and long-range performance at an accessible price. Available now for a launch price of €2,599 (RRP €2,799), every Roam purchase also includes €90 worth of complimentary accessories for a limited time.

Built around the needs of modern trekking riders, MapFour Roam was created to solve common challenges in the category, including stiff rides, limited terrain capability, and high costs for premium features. Inspired by leading trekking models, Roam combines full-suspension comfort, smart IoT protection, and low-maintenance engineering to deliver smoother handling, safer travel, and all-terrain confidence across city streets, forest paths, and long-distance tours.

The launch follows a successful market debut across Europe. In June, MapFour opened its brand store in Amsterdam, marking an important milestone in the brand’s retail expansion. Later that month, Roam made its world premiere at Eurobike 2026, gaining attention from media, dealers, and industry professionals. In early July, the model was showcased again at Prodays Paris, where its French Design Award recognition and premium riding experience received positive feedback from dealers and test riders.

MapFour Roam Key Highlights

Full-Suspension Trekking Design with 100mm front and 60mm rear suspension for enhanced comfort and stability.Smart System with GPS navigation, anti-theft protection, real-time ride tracking, and customizable riding modes.100Nm Mid-Drive Motor with belt drive and Shimano Nexus 5 hub for powerful, smooth, and low-maintenance performance.720Wh LG Battery delivering up to 150km range (ECO mode) with 2-hour fast charging.Fully equipped with integrated lights, fenders, and rear carrier for commuting, touring, and adventure rides.

Roam marks the beginning of MapFour’s journey as an independent brand, built around delivering premium riding experiences with outstanding value. Looking ahead to autumn 2026, MapFour will further expand its presence across Germany, France, the Netherlands, Belgium, and Luxembourg through community riding events and partnerships with outdoor camping brands, creating more opportunities for riders to experience the brand while supporting long-term dealer growth.

Driven by the mission of providing sustainable, economical, healthier, and worry-free mobility, MapFour is committed to making premium and comfortable riding experiences accessible to more riders.

For more information about the MapFour Roam and partnership opportunities, please visit the official MapFour website.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/mapfour-roam-officially-launches-bringing-premium-trekking-experience-within-reach-302842048.html

Continue Reading

Technology

Schreiber Foods and Ascendion Announce Strategic Partnership to Transform Global Operations and Software Development Using Agentic AI

Published

on

By

Multi-year strategic partnership will advance global operations for one of the world’s largest food and beverage companies to accelerate growth and enhance customer service.
 

GREEN BAY, WI, and BASKING RIDGE, NJ, Aug. 5, 2026 /PRNewswire/ — Schreiber Foods and Ascendion today announced a multi-year strategic partnership to transform Schreiber’s global operations and software development using agentic AI, advancing the company’s vision to do good through food. Through this partnership, Ascendion will equip Schreiber’s capability centers with AI-native technology to fuel sustainable growth and accelerate innovation across more than 40 locations on five continents.

As a trusted food and beverage supplier to the world’s leading retailers, restaurants, distributors, and food manufacturers, Schreiber’s products feed families in more than 95 countries and its global IT capability centers serve more than 10,000 employee-partners worldwide.

“To fuel Schreiber’s next era of rapid growth, we are taking a bold, transformational leap forward in how we operate and serve our customers,” said Trevor Farrell, President of Schreiber Foods. “By leaning into next-generation, agentic AI with Ascendion, we are reinforcing the very foundation of what our customers rely on us for: world-class quality, safety, and service. This technology will empower our employee-partners, accelerate our innovation, and allow us to deliver even greater impact at scale.”

Through the partnership, AI agents will help Schreiber and Ascendion teams get quality and food safety signals to decision-makers faster, modernize the ERP environment, and give regional teams a more unified way to collaborate. Over time, repetitive, high-volume technology work will increasingly be performed by AI agents, freeing Schreiber’s engineers and analysts to focus on work that requires human judgment and creativity. Ascendion’s proprietary Engineering to the Power of AI method and tools will balance work across people and AI to ensure security, privacy, compliance, and ethical alignment.

For Ascendion, the engagement reflects what Chief Executive Officer Karthik Krishnamurthy described as a special kind of responsibility. “Schreiber Foods’ mission is one of the most consequential out there. We are honored to deploy technology that helps Schreiber bring food to people all over the world,” Krishnamurthy said. “Schreiber leaders recognize the impact that can be unlocked by AI-native operations across their global network. It’s a bold vision built on a powerful foundation of success, and we’re thrilled to bring the full power of AI to this partnership.”

Technology is at the core of the partnership. Schreiber has deployed multiple AI tools, and the Ascendion partnership builds on that foundation. Ascendion will leverage AAVA, its proprietary agentic AI platform, to accelerate AI across capability center workflows, drive accelerated decisions on the plant floor, provide stronger traceability across geographies, and lower the technology cost base while increasing operational resilience for the next phase of growth.

“AI is a significant driver of transformation, but its real strength lies in how it empowers our people,” said Sri Kantamneni, Executive Vice President, Chief Information & Digital Officer at Schreiber Foods. “Through this strategic collaboration with Ascendion, we’re equipping our capability centers with AI-native tools that elevate our internal service and operational standards. By giving our employee-partners better, smarter tools to work with, we enable them to focus less on manual processes and more on driving customer success and accelerating our growth.”

“We’re accountable for outcomes, not effort,” added Dharam Gurbani, Chief Growth Officer at Ascendion. “What changes for Schreiber Foods’ plants, customers, and consumers is the only scorecard that matters. Our partnership will re-set expectations for velocity, efficiency, and operational excellence across capability centers in the United States, Mexico, India, Spain, and Poland. We are grateful for the trust Schreiber is putting in Ascendion, and we’re excited to accelerate toward the future.”

To know more about the Schreiber collaboration, click here.

About Schreiber Foods

Schreiber Foods strives to do good through food every day. Based in North America, Schreiber is an employee-owned, customer-brand leader in cream cheese, natural cheese, process cheese, beverages and yogurt. Its more than 10,000 employees and presence on five continents enable Schreiber to be an essential ingredient in its customers’ success. With annual sales of more than $7 billion, Schreiber partners with the best retailers, restaurants, distributors and food manufacturers around the globe. Schreiber also recognizes its responsibility to do good in the world and is driven to make a difference in everything it does.

About Ascendion

Ascendion is an AI-native software engineering company that partners with global enterprises to drive agentic transformation across how they build, modernize, and operate software. AAVA™, Ascendion’s proprietary agentic AI platform, brings expert engineers and AI agents together as one operating model, closing the last mile between ambition and outcome and turning velocity into measurable business results. The result: faster time-to-market and value that compounds over time. Find out more at www.ascendion.com.

Engineering to the Power of AI and AAVA are trademarks or service marks of Ascendion®. AAVA™ is pending registration. Unauthorized use is strictly prohibited.

View original content to download multimedia:https://www.prnewswire.com/news-releases/schreiber-foods-and-ascendion-announce-strategic-partnership-to-transform-global-operations-and-software-development-using-agentic-ai-302843505.html

SOURCE Ascendion

Continue Reading

Trending